Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 517-518

  Gugenheim, J ^a,b   Baldini, E ^a   Ouzan, D ^a   Mouiel, J ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; VIRUS ANTIBODY; VIRUS DNA;

ADULT; CONFERENCE PAPER; DNA DETERMINATION; DOSE RESPONSE; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; REINFECTION; RISK FACTOR; VIRUS REPLICATION;

ACTUARIAL ANALYSIS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; VIRUS REPLICATION;

EID: 0030901015     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00247-3     Document Type: Conference Paper

References (8)

1. Van Thiel DH, Wright HI, Fagiuoli S: Hepatology 20:20, 1994
2. Gugenheim J, Crafa F, Fabiani P, et al: Transplant Proc 25:1349, 1993
3. Samuel D, Muller R, Alexander G: N Engl J Med 329:1842, 1993
4. Gugenheim J, Samuel D, Saliba F, et al: Transplant Proc 19:3805, 1987
5. Todo S, Demetris AJ, Van Thiel D, et al: Hepatol 13:619, 1991
6. Müller R, Gubernatis G, Farle M, et al: J Hepatol 13:90, 1991
7. Krogsgaard K, Kryger P, Aldershvile J, et al: Hepatol 7:42, 1987
8. Zignego AL, Samuel D, Gugenheim J, et al. In Zuckermann AJ (ed): Viral Hepatitis and Liver Disease. New York: Alan R Liss, 1988, p 808